Double Blind, Placebo-Controlled Study Finds Vaporized Cannabis Helpful in Treating Neuropathic Pain
Recently a double blind, placebo-controlled, crossover study looked at patients who suffered from neuropathic pain, and didn’t get much relief from traditional medication, to determine if vaporized cannabis could be helpful. It found, in clear terms, that it is.
The study, conducted by researchers at the University of California Davis Medical Center and published in The Journal of Pain, was given the title “Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain”.
Participants were given doses of cannabis with either a really low amount of THC (3.53) or an extremely low amount of THC (1.29 percent, barely putting it above hemp). Some of the participants also received a placebo that contained no THC.
Researchers found both doses of cannabis to be effective in significantly reducing the patient’s pain. According to the study’s abstract, “Vaporized cannabis, even at low doses, may present an effective option for patients with treatment-resistant neuropathic pain.”
You can read the entirety of the study by clicking here.